drugset / Trial / NCT03199950

PROfylactic Haloperidol in Patients Defined as High Risk for DElirium With Delirium Risk mOdel

NCT03199950

Phase 4 Unknown 1366 enrolled Zuyderland Medical Center
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The hospital pharmacy at the Zuyderland Medical Centre developed the DElirium MOdel (DEMO) to predict which patients are at risk of developing a delirium in patients aged 60 or older. With this delirium risk prediction model we aim to predict more accurately which patients are at high risk of developing a delirium and want to investigate if these patients can benefit from prophylactic haloperidol.

Timeline

Start
2017-06-23
Primary completion
2018-11-23
Completion
2018-11-23

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Haloperidol Other / unclassified 1 mg Oral

Indications